Combinations comprising mGluR modulators for the treatment of parkinson's disease

Details for Australian Patent Application No. 2009265760 (hide)

Owner Novartis AG

Inventors Gomez-Mancilla, Baltazar; Gasparini, Fabrizio

Agent Davies Collison Cave

Pub. Number AU-A-2009265760

PCT Pub. Number WO2010/000763

Priority 61/076,772 30.06.08 US

Filing date 30 June 2009

Wipo publication date 7 January 2010

International Classifications

A61K 31/404 (2006.01)

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/4545 (2006.01)

A61K 31/465 (2006.01) - Nicotine

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/4725 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

Event Publications

20 January 2011 PCT application entered the National Phase

  PCT publication WO2010/000763 Priority application(s): WO2010/000763

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009265775-An improved method of brewing beer

2009265753-Detection of shed CD31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways